Company Filing History:
Years Active: 2014-2016
Title: A Stewart Campbell: Innovator in Synthetic Oligosaccharides
Introduction
A Stewart Campbell is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of immunology, particularly through his work on synthetic oligosaccharides for vaccines. With a total of 2 patents, Campbell's innovations are paving the way for advancements in vaccine development.
Latest Patents
One of Campbell's latest patents focuses on synthetic lipooligosaccharide (LOS)-based oligosaccharides and conjugates. This invention includes various serotype-specific oligosaccharide antigens and core oligosaccharide structures corresponding to major serotypes. The oligosaccharides can be synthesized using a chemical assembly methodology that relies on a limited number of monosaccharide and disaccharide building blocks. Additionally, the invention provides LOS-based immunogenic and immunoprotective compositions, along with antibodies derived from these compositions, aimed at diagnosing, treating, and preventing infections.
Career Highlights
Throughout his career, Campbell has worked with several prominent companies, including Visterra, Inc. and Ancora Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in the field of vaccine development and immunology.
Collaborations
Some of Campbell's notable coworkers include Gregory Lohman and Obadiah Joseph Plante. Their collaborative efforts have likely enhanced the innovative work being done in the realm of synthetic oligosaccharides.
Conclusion
A Stewart Campbell's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact vaccine development and the fight against infectious diseases.